Masimo | MASI - Ebitda


Masimo reported $72M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Align Technology USD 203.61M 66M Jun/2025
AtriCure USD 17.8M 2.45M Sep/2025
Avanos Medical USD -63.9M 85.5M Jun/2025
Baxter International USD 462M 137M Jun/2025
Becton, Dickinson and Co. USD 2.15B 674M Sep/2025
Boston Scientific USD 1.37B 9M Jun/2025
Dexcom USD 368.4M 59.6M Sep/2025
Edwards Lifesciences USD 469M 57.7M Jun/2025
General Electric Aerospace USD 3.04B 185M Sep/2025
Globus Medical USD 252.6M 43.92M Sep/2025
Haemonetics USD 115.53M 9.22M Sep/2025
Insulet USD 160M 2.5M Sep/2025
Integra LifeSciences USD 78.45M 550.67M Sep/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
Masimo USD 72M 42.6M Jun/2025
Medtronic USD 2.44B 139M Sep/2025
Owens Minor USD 96.6M 12.17M Jun/2025
ResMed USD 547.48M 27.46M Dec/2025
Steris USD 367.2M 13.42M Jun/2025
Stryker USD 1.67B 206M Sep/2025
Tandem Diabetes Care USD 2.77M 4.62M Sep/2025
Teleflex USD 207.62M 15.28M Jun/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Zimmer Biomet Holdings USD 575.7M 26.1M Jun/2025